Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-30T15:06:06.970Z Has data issue: false hasContentIssue false

Association between G6PD deficiency and schizophrenia A case report

Published online by Cambridge University Press:  27 August 2024

B. Abassi*
Affiliation:
1Ibn Omrane, Razi Hospital, Mannouba, Tunisia
F. Fekih-Romdhane
Affiliation:
1Ibn Omrane, Razi Hospital, Mannouba, Tunisia
F. Baccar
Affiliation:
1Ibn Omrane, Razi Hospital, Mannouba, Tunisia
M. Cheour
Affiliation:
1Ibn Omrane, Razi Hospital, Mannouba, Tunisia
R. Damak
Affiliation:
1Ibn Omrane, Razi Hospital, Mannouba, Tunisia
S. Ellini
Affiliation:
1Ibn Omrane, Razi Hospital, Mannouba, Tunisia
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

G6PD is essential for the production of NADPH, which is a cofactor for many enzymes involved in antioxidant defense and neurotransmitter synthesis. A deficiency in this enzyme could lead to increased oxidative stress, impaired neurotransmitter and immune function. The latter have been implicated in the pathophysiology of schizophrenia.

Objectives

The present case is presented to underscore the infrequent and uncharacteristic manifestation of this condition, in the context of clinical symptoms and the trajectory of evolution of schizophrenia when associated with G6PD Deficiency. Moreover, it sheds light on the challenges clinicians encounter in the management of such cases.

Methods

A case report of a patient who was admitted to the Psychiatry Department (“Ibn Omrane”) of Razi Hospital”.

Results

Mr. M.T is a 26 year-old unmarried man. He comes from a non-consanguineous marriage and has an educational level of a bachelor’s degree plus three additional years of study. He has a significant family medical history. His maternal uncle is under treatment for a chronic psychotic disorder. He has a personal history of G6PD deficiency and no specific habits to note. At the age of 24, he insidiously developed anxiety with incoherent statements of persecution accompanied by behavioral manifestations leading to mistrust and social isolation. He discontinued his studies for a year and began verbalizing suicidal thoughts accompanied by self-harm behaviors.

The family sought help from a psychiatrist who prescribed 5 mg of olanzapine, which was covertly administered to the patient.

At the age of 28, after a suicide attempt, he was involuntarily admitted to Razi Hospital. The clinical presentation was dominated by disorganization, with a partial response to treatment.

Conclusions

More research is needed to confirm the association between G6PD deficiency and schizophrenia and to determine the underlying mechanisms. Larger studies with well-defined populations and methodologies are needed. It is also important to study the interaction between G6PD deficiency and other genetic and environmental factors that contribute to schizophrenia.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.